# US 2014/0235492 A1 · Methods for preparing single domain antibody microarrays

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0235492 A1
- Document ID: US20140235492A1
- Status: Published application
- Kind: A1
- Application number: 14/345,660
- Filed: 2011-09-20
- Published: 2014-08-21
- Earliest claimed: 2011-09-20
- Assignees: Institut National de la Sante et de la Recherche Medicate (INSERM); Universite D'Aix-Marseille
- Inventors: Daniel Baty; Patrick Chames; Klervi Even-Desrumeaux
- Web page: https://patentgrep.com/patent/US20140235492A1

## CPC

- G01N 33/531: Production of immunochemical test materials
- C07K 16/114: Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
- C07K 16/18: against material from animals or humans
- C07K 16/3007: {Carcino-embryonic Antigens}
- C07K 16/3015: {Breast}
- C07K 16/32: against translation products of oncogenes
- G01N 33/54353: {with ligand attached to the carrier via a chemical coupling agent (coatings G01N33/54393)}
- C07K 2317/22: from camelids, e.g. camel, llama or dromedary
- C07K 2317/569: Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
- C07K 2319/90: containing a motif for post-translational modification
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention relates to a method for preparing sd Ab microarray comprising the step consisting of: —i) providing a host cell capable of expressing a biotinylation enzyme —ii) transforming said host cell with a nucleic acid encoding for a fusion protein wherein a single domain antibody is fused at its carboxy terminal end to a biotinylation peptide —iii) culturing said host cell in presence of biotin in such a way that said fusion protein and biotinylation enzyme are expressed, resulting in biotinylation of said fusion protein —iv) lysing said host cell as cultured at step iii) —v) spotting the lysate obtained at step iv) on a solid sup port coated with an agent selected from the group consisting of avidin, streptavidin and/or any art known derivative of these agents A further object of the invention relates to a sd Ab microarray obtainable by the method of the invention.

## Claims

### Claim 1

A method for preparing a single domain antibody (sdAb) microarray comprising the steps of:
i) providing a host cell capable of expressing a biotinylation enzyme
ii) transforming said host cell with a nucleic acid encoding for a fusion protein comprising a sdAb fused at its carboxy terminal end to a biotinylation peptide
iii) culturing said host cell in presence of biotin in such a way that said fusion protein is expressed, resulting in biotinylation of said fusion protein
iv) lysing said host cell as cultured at step iii) and
v) spotting the lysate obtained at step iv) on a solid support coated with an agent selected from the group consisting of avidin, streptavidin and/or a derivative of avidin or streptavidin.

### Claim 2 (depends on 1)

The method according to claim 1 wherein the host cell can naturally express the biotinylation enzyme or was previously transformed with a nucleic acid encoding for the biotinylation enzyme.

### Claim 3 (depends on 1)

The method according to claim 1 wherein the host cell is E. coli and the biotinylation enzyme is BirA.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the biotinylation peptide is a BirA substrate sequence tag.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the single domain antibody and the biotinylation peptide are fused directly or via a spacer.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the single domain antibody is specific for a cancer antigen or specific for a virus, a bacteria or a parasite associated target.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the solid support is selected from the group consisting of beads, plates, cuvettes, filters, and titer plates.

### Claim 8

A single domain antibody (sdAb) microarray obtained by
i) providing a host cell capable of expressing a biotinylation enzyme
ii) transforming said host cell with a nucleic acid encoding for a fusion protein comprising a sdAb fused at its carboxy terminal end to a biotinylation peptide
iii) culturing said host cell in presence of biotin in such a way that said fusion protein is expressed, resulting in biotinylation of said fusion protein
iv) lysing said host cell as cultured at step iii) and
v) spotting the Mate obtained at step iv) on a solid support coated with an agent selected from the group consisting of avidin, streptavidin and/or a derivative of avidin or streptavidin.

### Claim 9 (depends on 8)

The sdAb microarray according to claim 8, wherein said sdAb microarray comprises a sole type of sdAb directed against the same antigen, or with different kinds of sdAbs directed against various antigens.

### Claim 10 (depends on 8)

The sdAb microarray according to claim 8 wherein the solid support of the sdAb array is a cytometric bead for use in flow cytometry.

### Claim 11

A method for detecting a plurality of antigens comprising the steps of
providing a single domain antibody (sdAb) array by
i) providing a host cell capable of expressing a biotinylation enzyme
ii) transforming said host cell with a nucleic acid encoding for a fusion protein comprising a sdAb fused at its carboxy terminal end to a biotinylation peptide
iii) culturing said host cell in presence of biotin in such a way that said fusion protein is expressed, resulting in biotinylation of said fusion protein
iv) lysing said host cell as cultured at step iii) and
v) spotting the lysate obtained at step iv) on a solid support coated with an agent selected from the group consisting of avidin, streptavidin and/or a derivative of avidin or streptavidin,
contacting the array with a sample containing antigens, and
detecting antigens that bind to the array.
